Skip to content Skip to navigation

ChEM-H media coverage

Aug 10 2016 | NPR
NPR interviewed ChEM-H ungraduate students who have started a company to tackle antibiotic resistant bacteria. 
Aug 7 2016 | StartupBank
Stanford ChEM-H Entrepreneurship students have created a startup to tackle antibiotic resistant bacteria. 
Jul 27 2016 | Scope blog
Shan Wang developed a new technique for measuring protein interactions, and in the process uncovered a novel interaction that could lead to immunotherapy drugs to treat cancer. 
Jun 20 2016 | The Economic Times
Jennifer Cochran worked with the ChEM-H Medicinal Chemistry Knowledge Center to develop a novel approach to treating cancer. 
Jun 9 2016 | The Pew Charitable Trusts
ChEM-H Faculty Fellow Lei Stanley Qi named Pew Scholar in the Biomedical Sciences, a prestigious award for early-career scientists.
May 2 2016 | Science Alert
ChEM-H faculty fellows Chaitan Khosla, Michael Bassik, and others from the ViRx@Stanford team identified a previously abandoned drug that is effective against two human viruses.
Feb 19 2016 | Stanford Medicine
ChEM-H fellows Christina Smolke and Elizabeth Sattely investigate engineering organisms to produce drugs.
Feb 9 2016 | Scope blog
Peter Kim discusses why he thinks he’ll succeed where so many have failed in their efforts to develop an HIV vaccine, and the importance of working across disciplines.
Feb 8 2016 | National Academy of Engineering
The National Academy of Engineering announced ChEM-H faculty fellow Peter Kim as a newly elected member.
Jan 26 2016 | Science Daily
ChEM-H fellow Matthew Bogyo reviews optical probes that light up cancer cells, which are meant to improve tumor removal.
Jan 5 2016 | The Atlantic
ChEM-H faculty fellow Stanley Qi and colleagues have modified the popular gene-editing enzyme CRISPR to serve as a powerful tool and potential novel therapeutic approach.
Dec 17 2015 | Nature News
ChEM-H faculty fellow Christina Smolke named one of Nature's "ten people who mattered this year" for her work to produce opioids in yeast.
Sep 10 2015 | Reuters
ChEM-H member Elizabeth Sattely identified the molecular machinery used by a rare plant to make a cancer drug, and inserted those enzymes into a common laboratory plant. This work could create a more stable and flexible way of producing an effective drug.
Aug 3 2015 | Forbes
ChEM-H postdoctoral fellow David Hewings and his colleagues in the Kool research group at Stanford have discovered a catalyst to help recover RNA from preserved tissue samples.
Feb 19 2015 | Scope blog
Anson Lowe and Mark Smith are working to develop a drug that could benefit people with several different types of cancer
Dec 19 2014 | Scope blog
Julie Fogarty, a graduate student in the lab of James Swartz, produced a podcast explaining the lab's work developing a universal flu vaccine.
Dec 17 2014 | The Stem Cellar Blog
Karen Dubbin, PhD candidate in the lab of Sarah Heilshorn, describes the lab's work developing a gel to protect therapeutic stem cells in a short video.
Dec 1 2014 | Scope blog
Rhiannon Thomas-Tran describes work she's doing in the lab of Justin Du Bois, synthesising molecules that could one day lead to a therapy for chronic pain. 
Oct 27 2014 | The Stanford Daily
Chaitan Khosla discusses the new ChEM-H building and the goals of the institute.


Subscribe to